Pluri (PLUR) Cash from Operations (2010 - 2025)
Pluri (PLUR) reported Cash from Operations of 5205000.0 for Q4 2025, down 12.47% year-over-year from 5946368.8 in Q4 2024, and up 4.11% quarter-over-quarter from 5428000.0 in Q3 2025.
Pluri (PLUR) Cash from Operations (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Cash from Operations data on file, last reported at 5205000.0 in Q4 2025.
- Cash from Operations for Q4 2025 came in at 5205000.0, down 12.47% year-over-year; the trailing twelve-month figure through Dec 2025 was 20152000.0 (down 17.12% YoY), and the FY2025 annual result was 18211000.0, down 1.05% from the prior year.
- Cash from Operations improved to 5205000.0 in Q4 2025 per PLUR's latest filing, from 5428000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 2897000.0 in Q2 2023 and troughed at 9863000.0 in Q4 2021.
- A 5-year average of 6157450.0 and a median of 5642500.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2021 and 2023: Cash from Operations slumped 51.8% in 2021, then surged 65.62% in 2023.
- A 5-year view of Cash from Operations shows it stood at 9863000.0 in 2021, then jumped by 36.33% to 6280000.0 in 2022, then soared by 41.89% to 3649000.0 in 2023, then dropped by 26.83% to 4628000.0 in 2024, then slipped by 12.47% to 5205000.0 in 2025.
- Business Quant data shows PLUR's Cash from Operations at 5205000.0 in Q4 2025, 5428000.0 in Q3 2025, and 5216000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -5.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.21 Mn |
| Dec 31, 2025 | -5.21 Mn |
| Sep 30, 2025 | -5.43 Mn |
| Sep 30, 2025 | -5.43 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Mar 31, 2025 | -4.30 Mn |
| Mar 31, 2025 | -4.30 Mn |
| Dec 31, 2024 | -4.63 Mn |
| Dec 31, 2024 | -4.63 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | -4.31 Mn |
| Jun 30, 2024 | -4.31 Mn |
| Mar 31, 2024 | -4.20 Mn |
| Mar 31, 2024 | -4.20 Mn |
| Dec 31, 2023 | -3.65 Mn |
| Dec 31, 2023 | -3.65 Mn |
| Sep 30, 2023 | -5.86 Mn |
| Sep 30, 2023 | -5.86 Mn |